Expert Panel Votes Against MDMA Therapy for PTSD Treatment
An expert panel in the United States has voted against the use of MDMA therapy for treating PTSD, citing concerns about the drug’s efficacy. Despite promising results from trials, panelists raised doubts about the long-term benefits and potential risks associated with the treatment. The FDA is expected to make a final decision by August 11, while Australia has approved the use of MDMA for therapy sessions.
Study Shows Promise of MDMA-Assisted Therapy for PTSD
A recent study published in Nature Medicine has revealed promising results for individuals suffering from moderate to severe post-traumatic stress disorder (PTSD). The research, conducted as a double-blinded randomized clinical trial, found that combining the drug MDMA with psychotherapy can…